Your browser doesn't support javascript.
loading
Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC.
Zhao, Jia; Liu, Hongbin; Hong, Zhixian; Luo, Wei; Mu, Wenqing; Hou, Xiaorong; Xu, Guang; Fang, Zhie; Ren, Lutong; Liu, Tingting; Wen, Jincai; Shi, Wei; Wei, Ziying; Yang, Yongping; Zou, Wenjun; Zhao, Jun; Xiao, Xiaohe; Bai, Zhaofang; Zhan, Xiaoyan.
Afiliación
  • Zhao J; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Liu H; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
  • Hong Z; School of Pharmacy, North SiChuan Medical College, Nanchong, 637000, China.
  • Luo W; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Mu W; Department of Pharmacy, Hebei Key Laboratory of Neuropharmacology, Hebei North University, Zhangjiakou, 075000, China.
  • Hou X; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Xu G; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Fang Z; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Ren L; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Liu T; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Wen J; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Shi W; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Wei Z; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Yang Y; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Zou W; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Zhao J; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Xiao X; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
  • Bai Z; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
  • Zhan X; Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China. zhj68@263.net.
Mol Med ; 29(1): 84, 2023 07 03.
Article en En | MEDLINE | ID: mdl-37400760
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Choque Séptico / Diabetes Mellitus Tipo 2 / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Choque Séptico / Diabetes Mellitus Tipo 2 / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: China